Fluciclovine PET/CT in Multiple Myeloma Patients

Recruiting

• Conditions: Myeloma, Multiple; PET-CT

• Registration Number: NCT03966443
• Lead Sponsor: Oslo University Hospital

Brief Summary

Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-01
• Status Verified: 2019-05
• Study First Submitted: 2019-05-27
• Study First Submitted QC: 2019-05-28
• Last Update Submitted: 2019-05-28
• Study First Posted: 2019-05-29
• Last Update Posted: 2019-05-30
• Primary Completion: 2020-01-31
• Study Completion: 2029-01-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Multiple myeloma patients suitable for ASCT treatment

Exclusion Criteria

• Patients with contraindications to ASCT treatment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparing of image findings at PET	1 year

Trial Locations

Locations (1)

Oslo University Hosptal; 🇳🇴 Oslo, Norway